Patents by Inventor Jaromir SYKORA

Jaromir SYKORA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11014991
    Abstract: The present invention relates to a specific CD95L antibody and to the use thereof in the treatment or diagnosis of diseases involving CD95L-induced signalling, e.g. cancer diseases.
    Type: Grant
    Filed: September 26, 2019
    Date of Patent: May 25, 2021
    Assignee: Apogenix AG
    Inventors: Christian Gieffers, Oliver Hill, Meinolf Thiemann, Jaromir Sykora, Christian Merz, Tim Schnyder, Harald Fricke
  • Publication number: 20200102397
    Abstract: The present invention relates to a specific CD95L antibody and to the use thereof in the treatment or diagnosis of diseases involving CD95L-induced signalling, e.g. cancer diseases.
    Type: Application
    Filed: September 26, 2019
    Publication date: April 2, 2020
    Inventors: Christian GIEFFERS, Oliver Hill, Meinolf Thiemann, Jaromir Sykora, Christian Merz, Tim Schnyder, Harald Fricke
  • Patent number: 10428154
    Abstract: The present invention relates to a specific CD95L antibody and to the use thereof in the treatment or diagnosis of diseases involving CD95L-induced signalling, e.g. cancer diseases.
    Type: Grant
    Filed: March 21, 2018
    Date of Patent: October 1, 2019
    Assignee: Apogenix AG
    Inventors: Christian Gieffers, Oliver Hill, Meinolf Thiemann, Jaromir Sykora, Christian Merz, Tim Schnyder, Harald Fricke
  • Patent number: 10266600
    Abstract: The present invention relates to a specific CD95L antibody and to the use thereof in the diagnosis of a cancer disease.
    Type: Grant
    Filed: October 26, 2016
    Date of Patent: April 23, 2019
    Assignee: APOGENIX AG
    Inventors: Harald Fricke, Christian Gieffers, Jaromir Sykora
  • Publication number: 20180208664
    Abstract: The present invention relates to a specific CD95L antibody and to the use thereof in the treatment or diagnosis of diseases involving CD95L-induced signalling, e.g. cancer diseases.
    Type: Application
    Filed: March 21, 2018
    Publication date: July 26, 2018
    Inventors: Christian GIEFFERS, Oliver HILL, Meinolf THIEMANN, Jaromir SYKORA, Christian MERZ, Tim SCHNYDER, Harald FRICKE
  • Publication number: 20170044264
    Abstract: The present invention relates to a specific CD95L antibody and to the use thereof in the diagnosis of a cancer disease.
    Type: Application
    Filed: October 26, 2016
    Publication date: February 16, 2017
    Inventors: Harald Fricke, Christian GIEFFERS, Jaromir Sykora
  • Publication number: 20160103132
    Abstract: The present invention relates to a method for diagnosing a cancer disease, comprising (a) determining the expression of CD95L in a cancer sample, and (b) classifying the cancer disease according the level of CD95L expression.
    Type: Application
    Filed: October 27, 2015
    Publication date: April 14, 2016
    Inventors: Harald FRICKE, Christian GIEFFERS, Jaromir SYKORA